TTP399 400 mg
TTP399-202
Phase 2 small_molecule completed
Quick answer
TTP399 400 mg for Diabetes Mellitus, Type 2 is a Phase 2 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- vTv Therapeutics
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed